These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3058463)
21. GnRH release from the mediobasal hypothalamus. In vitro regulation by oxytocin. Gambacciani M; Yen SS; Rasmussen DD Neuroendocrinology; 1986; 42(2):181-3. PubMed ID: 3005897 [TBL] [Abstract][Full Text] [Related]
22. Neuropeptide-Y stimulation of luteinizing hormone-releasing hormone secretion from the median eminence in vitro by estrogen-dependent and extracellular Ca2+-independent mechanisms. Sabatino FD; Collins P; McDonald JK Endocrinology; 1989 May; 124(5):2089-98. PubMed ID: 2651093 [TBL] [Abstract][Full Text] [Related]
23. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH. Kalra PS; Fuentes M; Sahu A; Kalra SP Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323 [TBL] [Abstract][Full Text] [Related]
24. Maturation of the prolactin and proopiomelanocortin-derived peptide responses to ether stress and morphine: neurochemical analysis. Johnston CA; Negro-Vilar A Endocrinology; 1986 Feb; 118(2):797-804. PubMed ID: 3002767 [TBL] [Abstract][Full Text] [Related]
25. Opioid modulation of gonadotropin releasing hormone release from the hypothalamic preoptic area in the pig. Barb CR; Chang WJ; Leshin LS; Rampacek GB; Kraeling RR Domest Anim Endocrinol; 1994 Oct; 11(4):375-82. PubMed ID: 7828431 [TBL] [Abstract][Full Text] [Related]
26. Release of luteinizing hormone-releasing hormone: interrelations between eicosanoids and catecholamines. Saadi M; Gerozissis K; Dray F Brain Res; 1989 May; 488(1-2):97-104. PubMed ID: 2501000 [TBL] [Abstract][Full Text] [Related]
27. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback. Advis JP; McCann SM; Negro-Vilar A Endocrinology; 1980 Oct; 107(4):892-901. PubMed ID: 6997020 [TBL] [Abstract][Full Text] [Related]
28. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig. Giri M; Kaufman JM Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937 [TBL] [Abstract][Full Text] [Related]
29. Opioidergic modulation of N-methyl-D,L-aspartic-acid-stimulated LH release in young adult but not older male mice. Miller GM; Gibson MJ Neuroendocrinology; 1994 Mar; 59(3):277-84. PubMed ID: 8159277 [TBL] [Abstract][Full Text] [Related]
30. Evidence for a spontaneous nitric oxide release from the rat median eminence: influence on gonadotropin-releasing hormone release. Knauf C; Prevot V; Stefano GB; Mortreux G; Beauvillain JC; Croix D Endocrinology; 2001 Jun; 142(6):2343-50. PubMed ID: 11356681 [TBL] [Abstract][Full Text] [Related]
31. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge. Sahu A; Crowley WR; Kalra SP Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749 [TBL] [Abstract][Full Text] [Related]
32. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+. Kalra PS; Kalra SP Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642 [TBL] [Abstract][Full Text] [Related]
33. Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes. Shu C; Selmanoff M Endocrinology; 1988 Jun; 122(6):2699-709. PubMed ID: 3131121 [TBL] [Abstract][Full Text] [Related]
34. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1. Rance N; Wise PM; Selmanoff MK; Barraclough CA Endocrinology; 1981 May; 108(5):1795-802. PubMed ID: 6783392 [TBL] [Abstract][Full Text] [Related]
35. Role of endogenous opioid peptides in mediating progesterone-induced disruption of the activation and transmission stages of the GnRH surge induction process. Richter TA; Spackman DS; Robinson JE; Dye S; Harris TG; Skinner DC; Evans NP Endocrinology; 2001 Dec; 142(12):5212-9. PubMed ID: 11713217 [TBL] [Abstract][Full Text] [Related]
37. Central nervous system peptide and amino acid modulation of luteinizing hormone and prolactin secretion in the pig. Kraeling RR; Barb CR; Leshin LS; Rampacek GB J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):79-103. PubMed ID: 1343978 [TBL] [Abstract][Full Text] [Related]
38. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin. Aguila MC; McCann SM Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865 [TBL] [Abstract][Full Text] [Related]
39. Endogenous opioid peptides contribute to suckling-induced prolactin release by suppressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons. Arbogast LA; Voogt JL Endocrinology; 1998 Jun; 139(6):2857-62. PubMed ID: 9607794 [TBL] [Abstract][Full Text] [Related]
40. The effect of adrenoreceptor antagonists and agonists on LHRH release from the stalk-median eminence in the pig. Wasowicz G; Elsaesser F; Ziecik AJ Acta Physiol Hung; 1997-1998; 85(1):51-63. PubMed ID: 9530436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]